
389: Hims' Super Bowl fallout, and the FDA reverses course
The Readout Loud
00:00
Impact on other compounders and telehealth firms
Katie discusses industry attention, widespread compounded GLP-1 forms, and potential knock-on effects.
Play episode from 22:58
Transcript


